MaxCyte Stock (NASDAQ: MXCT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 556.07K |
Day Range | - - - |
52 Wk Range | 2.45 - 5.55 |
Market Cap | $459.99M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 3.92% |
Days to Cover | 4.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MaxCyte (NASDAQ:MXCT) through any online brokerage.
Other companies in MaxCyte’s space includes: Harvard Bioscience (NASDAQ:HBIO), 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS) and Lifecore Biomedical (NASDAQ:LFCR).
There is no analysis for MaxCyte.
MaxCyte has a consensus price target of $11.00.
The stock price for MaxCyte (NASDAQ: MXCT) is $4.4 last updated July 19, 2024 at 4:00 PM EDT.
There are no upcoming dividends for MaxCyte.
MaxCyte’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for MaxCyte.
MaxCyte is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.